- Altimmune rises as GLP-1/GIP drug curbs heavy drinking in mid-stage studyPemvidutide showed a “highly statistically significant” treatment effect in patients with alcohol use disorder. Altimmune is going up against Eli Lilly and newcomer Baseline Therapeutics in this sp…BioSpace · 22m ago↗ source
- An eye drug biotech banks $118M and stocks its executive suite<figure><div><img src="https://imgproxy.divecdn.com/cIH1PfJposjsKezbbrmwTwtzNlhqTiIaZ_OaEGGTHE8/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNjE5NzI0MTUxLmpwZ…BioPharma Dive · 1h ago↗ source
- The FDA was all in on AI. Will that change?<figure><div><img src="https://imgproxy.divecdn.com/SbY7pjJU5zpd9fYni9dr5J14qHlA98Kk2ofoQajpOLE/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9UVFIyNUguanBn.webp"/></div></figur…